Prelude Capital Management’s CME Group CME Stock Holding History

Prelude Capital Management’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-4,900	Closed	-$1.3M	–	1046
2025 Q1	$1.3M	Sell	4,900 -600	-11%	-$148K	0.1%	250
2024 Q4	$1.28M	Buy	+5,500	New	+$1.26M	0.08%	313
2021 Q2	–	Sell	-35,000	Closed	-$7.15M	–	1678
2021 Q1	$7.15M	Hold	35,000	–	–	0.18%	68
2020 Q4	$6.37M	Buy	+35,000	New	+$5.95M	0.16%	72
2019 Q2	–	Sell	-5,000	Closed	-$823K	–	1731
2019 Q1	$823K	Buy	+5,000	New	+$884K	0.05%	373

Other funds holding CME

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Prelude Capital Management's CME Position: Q2 2026 in Review

Prelude Capital Management increased its CME Group (CME) stake by 225% in Q2 2026, buying an estimated $607K and bringing the position to 3,169 shares worth $700K. The position accounts for 0.05% of the portfolio, ranked #410.

Prelude Capital Management first reported a position in CME in Q1 2015 and has held it in 24 quarters since. The position peaked at $4.3M in Q3 2018. 1,706 funds tracked by Wall St. Rank hold CME as of Q2 2026.

Prelude Capital Management held 3,169 shares of CME Group worth $700K as of Q2 2026.
Prelude Capital Management bought 2,193 CME Group shares in Q2 2026, an estimated $607K.
CME Group made up 0.05% of Prelude Capital Management's portfolio in Q2 2026, its #410 holding.
Prelude Capital Management first reported a position in CME Group in Q1 2015 and has held it in 24 quarters since.
Prelude Capital Management's CME Group position peaked at $4.3M in Q3 2018.
1,706 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.